News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,269 Results
Type
Article (41390)
Company Profile (278)
Press Release (671601)
Multimedia
Podcasts (65)
Webinars (15)
Section
Business (206741)
Career Advice (2016)
Deals (35829)
Drug Delivery (98)
Drug Development (82572)
Employer Resources (172)
FDA (16419)
Job Trends (15044)
News (349808)
Policy (32902)
Tag
Academia (2601)
Accelerated approval (8)
Adcomms (26)
Allergies (96)
Alliances (50428)
ALS (108)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (169)
Approvals (16408)
Artificial intelligence (323)
Autoimmune disease (28)
Automation (18)
Bankruptcy (362)
Best Places to Work (11787)
BIOSECURE Act (19)
Biosimilars (116)
Biotechnology (200)
Bladder cancer (94)
Brain cancer (36)
Breast cancer (366)
Cancer (2896)
Cardiovascular disease (206)
Career advice (1686)
Career pathing (30)
CAR-T (188)
CDC (31)
Cell therapy (502)
Cervical cancer (23)
Clinical research (67886)
Collaboration (1023)
Company closure (3)
Compensation (652)
Complete response letters (20)
COVID-19 (2640)
CRISPR (57)
C-suite (311)
Cystic fibrosis (110)
Data (2897)
Decentralized trials (2)
Denatured (20)
Depression (54)
Diabetes (344)
Diagnostics (6507)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (141)
Drug pricing (120)
Drug shortages (27)
Duchenne muscular dystrophy (122)
Earnings (88144)
Editorial (42)
Employer branding (21)
Employer resources (148)
Events (115859)
Executive appointments (880)
FDA (18019)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (926)
Gene editing (130)
Generative AI (26)
Gene therapy (370)
GLP-1 (789)
Government (4536)
Grass and pollen (5)
Guidances (180)
Healthcare (19106)
Huntington's disease (30)
IgA nephropathy (37)
Immunology and inflammation (143)
Immuno-oncology (8)
Indications (39)
Infectious disease (2803)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (58)
Intellectual property (116)
Interviews (312)
IPO (16759)
IRA (45)
Job creations (3666)
Job search strategy (1429)
Kidney cancer (14)
Labor market (51)
Layoffs (505)
Leadership (18)
Legal (7968)
Liver cancer (82)
Lung cancer (412)
Lymphoma (202)
Machine learning (9)
Management (58)
Manufacturing (371)
MASH (87)
Medical device (13512)
Medtech (13517)
Mergers & acquisitions (19772)
Metabolic disorders (836)
Multiple sclerosis (99)
NASH (17)
Neurodegenerative disease (112)
Neuropsychiatric disorders (31)
Neuroscience (2096)
NextGen: Class of 2025 (6589)
Non-profit (4530)
Now hiring (47)
Obesity (423)
Opinion (222)
Ovarian cancer (100)
Pain (102)
Pancreatic cancer (119)
Parkinson's disease (188)
Partnered (22)
Patents (292)
Patient recruitment (151)
Peanut (50)
People (58431)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21223)
Phase II (29880)
Phase III (22275)
Pipeline (1589)
Policy (197)
Postmarket research (2598)
Preclinical (9006)
Press Release (64)
Prostate cancer (143)
Psychedelics (34)
Radiopharmaceuticals (265)
Rare diseases (447)
Real estate (5978)
Recruiting (66)
Regulatory (22805)
Reports (50)
Research institute (2380)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (9)
RSV (48)
Schizophrenia (84)
Series A (153)
Series B (103)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3653)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (56)
The Weekly (43)
Vaccines (777)
Venture capital (50)
Weight loss (259)
Women's health (43)
Worklife (16)
Date
Last 7 days (625)
Last 30 days (2265)
Last 365 days (31933)
2025 (16390)
2024 (35830)
2023 (40562)
2022 (51763)
2021 (56297)
2020 (54613)
2019 (47121)
2018 (35505)
2017 (32702)
2016 (32069)
2015 (38109)
2014 (31793)
2013 (26753)
2012 (28953)
2011 (29683)
2010 (27642)
Location
Africa (728)
Alabama (66)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (39008)
Australia (6366)
California (7385)
Canada (2298)
China (675)
Colorado (317)
Connecticut (326)
Delaware (189)
Europe (85096)
Florida (1099)
Georgia (246)
Hawaii (1)
Idaho (60)
Illinois (647)
India (27)
Indiana (361)
Iowa (17)
Japan (223)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1030)
Massachusetts (5561)
Michigan (244)
Minnesota (451)
Mississippi (3)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (79)
New Hampshire (66)
New Jersey (2072)
New Mexico (28)
New York (2086)
North Carolina (1071)
North Dakota (10)
Northern California (3229)
Ohio (233)
Oklahoma (16)
Oregon (34)
Pennsylvania (1601)
Puerto Rico (17)
Rhode Island (36)
South America (1110)
South Carolina (33)
South Dakota (1)
Southern California (2746)
Tennessee (127)
Texas (1104)
United States (27512)
Utah (218)
Virginia (186)
Washington D.C. (75)
Washington State (625)
West Virginia (4)
Wisconsin (76)
713,269 Results for "f1 oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
June 10, 2025
·
4 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Acceptance of Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29, 2025
·
2 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
9 min read
Press Releases
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 29, 2025
·
4 min read
Press Releases
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody
May 21, 2025
·
5 min read
Press Releases
NorthSea Therapeutics Announces Publication of Positive Results from Phase 2b ICONA Clinical Trial of Icosabutate in Biopsy-Confirmed F1-F3 MASH in Journal of Hepatology
March 6, 2025
·
6 min read
Press Releases
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
7 min read
Press Releases
Predictive Oncology Inc. Issues Shareholder Letter Titled, “Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health”
May 20, 2025
·
7 min read
Press Releases
Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001
April 3, 2025
·
3 min read
Press Releases
Taiho Oncology to Share Data in Five Presentations, Including Two Oral Presentations, at the 2025 American Society of Clinical Oncology Annual Meeting
April 23, 2025
·
4 min read
1 of 71,327
Next
